Skip to main content
Premium Trial:

Request an Annual Quote

Expression Pathology Licenses Harvard’s AQUA Technology for Protein Quantification

NEW YORK (GenomeWeb News) - Expression Pathology said last week that it has licensed the patent rights to the AQUA protein quantification technology from Harvard University.
 
AQUA, a shortened form of “absolute quantification,” uses labeled peptide standards “to achieve absolute quantitation of target proteins in biological samples by mass spectrometry,” Expression Pathology said in a statement.
 
The company said it will combine AQUA with its own technologies for extracting proteins from formalin-fixed, paraffin-embedded tissues to develop new research and diagnostic applications.
 
Financial terms of the licensing agreement were not disclosed.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.